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I 
n this issue of the The Journal of Experimental Medicine, 
Boucher et al. (1) report on the role of the sphingomyelin 
pathway in CD28 signaling of NF-KB activation and mito- 
genesis in human Jurkat T ceils and in primary cultures of 
mouse splenic T cells. In contrast, two recent articles (2, 3) 
have reported that ceramide, the second messenger of the sphin- 
gomyelin pathway, triggers programmed cell death (apop- 
tosis) in response to exposure to ionizing radiation or activa- 
tion of Fas. Ceramide thus emerges as a pleiotropic biologic 
activator capable of inducing two mutually exclusive cellular 
functions, cell proliferation and cell death. This surprising 
finding provides tantalizing insight into the signaling capa- 
bilities  of ceramide specifically and  second  messengers  in 
general.  This commentary highlights several recent discov- 
eries on signaling through the sphingomyelin pathway and 
speculates on how ceramide might signal both proliferation 
and apoptosis. 
Signaling through the Sphingomyelin Pathway 
The sphingomyelin pathway is an ubiquitous signaling 
system linking a specific set of cell surface receptors to the 
nucleus. This pathway is initiated by hydrolysis of the phos- 
pholipid sphingomyelin (N-acylsphingosin-l-phosphocholine), 
which is preferentially concentrated in the plasma membrane 
of mammalian cells (4). Sphingomyelin hydrolysis occurs via 
that action of a sphingomyelin-specific  form of phospholi- 
pase C, a sphingomyelinase, to generate ceramide. Ceramide 
serves as a second messenger in this system, transmitting the 
message through to the cellular interior. Of note are the re- 
cent reports that have expanded the number of potential targets 
for ceramide stimulation and have questioned which sphin- 
gomyelinase-a neutral or an acidic form- might initiate fig- 
naling. Comprehensive  reviews on the sphingomyelin  pathway 
have been published during the past year (5-8). 
Sphingomyelinase is  known  to  exist  in  two  forms,  a 
Mg2+-dependent membrane-bound enzyme with a neutral 
pH optimum and a lysosomal acidic form (4). Mutations in 
the acidic sphingomyelinase gene are responsible  for the in- 
herited childhood disorder known as Niemann-Pick disease 
(9). Originally, it was believed that signaling was confined 
to the plasma membrane, involving only the neutral form, 
whereas the sole known function for the acidic form was for 
membrane turnover in the lysosomal compartment. How- 
ever, Kronke and colleagues (10) have suggested that at least 
a portion of the acidic form of sphingomyelinase may be ac- 
tivated at the plasma membrane by 1,2-diacylglycerol,  im- 
plicating it in signal transduction. Recent studies by Cifone 
et al. (3) show that activation of Fas results in stimulation 
of acidic sphingomyelinase in U937 cells and tends to sub- 
stantiate this notion. The involvement of a lysosomal hydro- 
lase in signaling is unprecedented and it is unclear how it 
might function in this capacity. It has been speculated that 
receptor internalization and subsequent acidification of en- 
dosomes might allow such a process to proceed. Although 
this is an intriguing hypothesis, it still implies that a portion 
of the acid sphingomyelinase must somehow be compartmen- 
talized separately from the remainder of the enzyme contained 
within the lysosome. The cloning of the acidic sphingomye- 
linase gene by Schuchman and co-workers (11) should allow 
these questions to be addressed. 
In addition to the membrane-associated enzyme, a cyto- 
solic variant of the neutral sphingomyelinase that is Mg  2+ - 
independent has  been  reported  and  partially  purified by 
Hannun and co-workers (12). The activity of this enzyme 
is enhanced within 1 h of vitamin D  stimulation of HL-60 
cells (13) and it has been suggested that this enzyme uses 
intracellular  sphingomyelin stores to initiate signaling (14). 
This attractive hypothesis configures the generation of cera- 
mide at sites other than the plasma membrane. Purification 
of this enzyme to homogeneity and determination of its amino 
acid sequence would appear essential for further progress in 
this field. 
Other exciting developments include the identification of 
multiple potential targets for ceramide stimulation. The first 
reported target for this activity was a 97-kD proline-directed 
serine/threonine protein kinase termed ceramide-activated  pro- 
tein kinase (15). This exclusively membrane-bound enzyme 
is tightly coupled to both TNF and IL-1 receptors based on 
reconstitution experiments performed in cell-free systems (16, 
17). This kinase is distinguished from other proline-directed 
protein kinases by its preference for the minimal substrate 
sequence -T-L-P (18). Sequences similar to this are found in 
a variety of potential substrates including the epidermal growth 
factor receptor and the protooncogene Raf. In fact, prelimi- 
nary data show that Raf is phosphorylated and thus activated 
by purified ceramide-activated  protein kinase  (19). 
Another potential membrane-bound target for ceramide 
in B and T cells is the protooncogene Vav. This protein has 
sequence homology to members of the family of guanine- 
nucleotide exchange proteins, which activate Ras by enhancing 
exchange of GDP for GTP. Vav contains, downstream of its 
putative catalytic domain, a cysteine-rich motif similar to the 
protein kinase C (PKC) lipid-binding domain that recognizes 
phorbol ester and 1,2-diacylglycerol (DG). Recently, Gulbins 
et al. (20) demonstrated that ceramide enhanced Vav exchange 
activity in vitro and in Vav preparations immunoprecipitated 
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ceramide-activated protein kinase and Vav might hypotheti- 
cally allow for coordinate activation of multiple elements of 
the MAP kinase cascade within the plasma membrane. Other 
guanine nucleotide exchange proteins would have to serve 
this function in nonhematopoietic cell systems for this to rep- 
resent  an  ubiquitous  signaling mechanism in  response to 
ceramide. 
Hannun and co-workers have published extensively on a 
cytosolic ceramide-activated protein phosphatase (CAPP) that 
is activated in vitro by ceramide (21). This protein is a cation- 
independent heterotrimetic protein phosphatase of the class 
PP2A, and it is inhibited by low concentrations of okadaic 
acid. Phosphatase activity was enhanced specifically by cera- 
mide but not by dihydroceramide. The ceramide binding site 
appears to be contained within the B subunit. In resting cells, 
CAPP is found in the cytosol, but it may translocate to mem- 
branes within a few minutes of cellular stimulation by TNF. 
This activity was found in Saccharomyces cerevisiae and was 
closely correlated to inhibition of proliferation by ceramide. 
The latter studies suggest that the sphingomyelin-signaling 
pathway may be evolutionarily conserved. 
PKC ~'may also be a direct target for ceramide stimulation 
(22).  Originally cloned by Nishizuka and co-workers, this 
kinase contains a lipid-binding domain and is stimulated by 
phospholipid (23).  However, in contrast to other members 
of the PKC family, neither phorbol ester nor DG activate 
PKC ~'. Recently, Moscat and colleagues showed that cera- 
mide enhanced the activity of purified PKC ~" in vitro (22). 
This group also showed that treatment of quiescent NIH- 
3T3 cells with a sphingomyelinase to elevate cellular cera- 
mide levels enhanced the I-KB phosphorylating activity of 
a PKC  ~" immunoprecipitate. 
The designation of numerous potential targets for cera- 
mide action leads to the conclusion that a complex pattern 
of integrated signals may be generated in response to acute 
elevation of cellular ceramide content. The fact that distinct 
end results are observed in response to ceramide raises the 
possibility that the targets for ceramide stimulation are differen- 
tially expressed in different cell types. Alternatively, the pat- 
tern of signal transmission and the ultimate outcome may 
be subject to transmodulatory regulation through other sig- 
naling systems. Thus, the readiness of the system to respond 
may be determined not only by genetics, but  may also be 
affected by external stimuli in a dynamic manner. 
Coordinate Signaling  through Ceramide and DG 
The simplest form of transmodulation would involve the 
interaction  of only one  signaling  system with  the sphin- 
gomyelin pathway. Such an interaction might lead to induc- 
tion of a set of events that neither system would otherwise 
express.  Costimulated activation of T  helper cells through 
the IL-1  and T  cell receptors may represent an example of 
this mode of coordinate signaling involving lipid second mes- 
sengers (24-26).  Specifically, as discussed below, this event 
may be reduced to its simplest form, the generation of cera- 
mide and DG,  respectively. 
DG and ceramide form the backbone of the glycerophos- 
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pholipids  and  sphingolipids,  respectively,  and  are rapidly 
released by receptor-induced activation of phospholipases  con- 
tained within the plasma membrane (4).  These molecules 
possess some structural and functional similarities.  Both are 
small molecules of ~600 D and are quite hydrophobic. Both 
molecules readily redistribute across a membrane bilayer,  a 
property that may be necessary for a lipid to serve as a second 
messenger. Furthermore, the level of these lipids appears to 
be tightly regulated in most cells at ~1-3 mol %  with re- 
spect to phospholipid. Perhaps the most convincing evidence 
for similarities between these two lipid second messengers 
is derived from studies that showed that  a number of en- 
zymes recognize both ceramide and DG as substrates.  For 
instance, Escherichia coli DG kinase phosphorylates both cer- 
amide and DG (27), and sphingomyelin synthase, the enzyme 
responsible for sphingomyelin synthesis in mammalian cells, 
transfers  the phosphocholine headgroup from DG to cera- 
mide, generating sphingomyelin from phosphatidylcholine. 
Other examples exist. 
While similarities clearly exist, there are substantive struc- 
tural and functional differences between DG and ceramide 
(28). Natural DG is comprised of two long-chain fatty acids 
of approximately equal chain length (C16-C20), whereas cer- 
amide frequently contains a 24-carbon fatty acid. This confers 
a more asymmetric structure onto ceramide. Natural cera- 
mide is also far more saturated than DG. Additionally, the 
amide-linked fatty acid at position 2,  the free hydroxyl at 
position 3,  and perhaps the trans double bond at positions 
4 and 5 of the sphingoid base backbone of ceramide present 
a significantly more polar region than the complementary 
region of DG. This allows for greater interaction with water 
and intra- and intermolecular hydrogen bonding, resulting 
in stabilization of the lipid bilayer. 
The structural similarities between DG and ceramide may 
be clues to those properties that may allow these lipids  to 
serve as second messengers, while the differences are recog- 
nized by mammalian cells and must determine specificity of 
function. In this regard, the isoforms of PKC stimulated by 
DG appear unaffected by ceramide, whereas PKC J" is recog- 
nized by ceramide but not by DG.  In fact, other than Vav, 
the identified targets for ceramide stimulation are not affected 
by DG. The ability of cellular targets to distinguish between 
these two lipids translates into specificity of action. Stimula- 
tion of ceramide-activated protein kinase (16), NF-xB trans- 
location to the nucleus (29), HIV replication (30) and apop- 
tosis in HL-60 cells (31), and IL-2 secretion in EL4 cells (17) 
were induced by ceramide but not DG (or other potential 
lipid second messengers) in these cells. 
Costimulation through the IL-1 and TCR may be inter- 
preted in terms of these two second messengers. It is well- 
documented that the TCR uses DG as a second messenger 
subsequent to activation of phospholipase Cy through one 
or more receptor-associated tyrosine kinases (26, 32-34). This 
function can be mimicked by low concentrations of phorbol 
ester,  a DG analogue, which in combination with IL-1  is 
used in costimulation assays for IL-2 secretion and IL-2 receptor 
up-regulation. As for the participation of ceramide in this 
costimulatory function, Mathias et al. have recently reported that the sphingomyelin pathway is the major signaling system 
for IL-1 in EL4 T  helper cells and that ceramide substitutes 
for IL-1 to costimulate IL-2 secretion (17). Hence, costimu- 
lation of IL-2 secretion was successfully recapitulated with 
lipid analogues of DG and ceramide.  The studies reported 
by Boucher et al. (1) similarly demonstrate recapitulation of 
costimulated signaling through CD28 and the TCR by a com- 
bination  of sphingomyelinase  and phorbol ester. 
The concept of costimulation allows interpretation of the 
role of ceramide as mediator of Fas- and TNF-induced apop- 
tosis to be viewed in the context of reciprocal regulation of 
cell death versus proliferation by lipid second messengers.  Cel- 
lular stimulation with bacterial sphingomyelinase, ceramide 
analogues,  or TNF induces apoptosis in sensitive cell lines 
concomitant with relatively large elevations in cellular cera- 
mide content and without effect on cellular DG levels (16, 
29, 31). This contrasts with the costimulation phenomenon 
through IL-1 or CD28 and the TCR, in which elevation of 
cellular ceramide content  likely occurs together  with DG, 
and proliferation and T cell activation ensue. Hence, the out- 
come of cellular stimulation may depend on whether single 
or dual second messenger stimulation is activated, and this 
variable may determine  the ultimate  outcome even within 
a single cell type.  In this regard,  two laboratories have re- 
cently demonstrated that isolated elevation of the ceramide 
level in Jurkat cells after stimulation with Fas or with cera- 
mide analogues induced apoptosis (3, 34a), whereas Boucher 
et al. (1) show that ceramide elevation concomitant with ac- 
tivation of the TCR (and presumably elevation of DG) resuhed 
in expression of differentiated functions and growth of the 
same cells. 
A number of studies have directly evaluated the potential 
role for reciprocal regulation  of apoptosis by ceramide and 
DG. Obeid et al.  reported that phorbol ester pretreatment 
of U937 promonocytic  leukemia  cells  blocked TNF-  and 
ceramide-induced  apoptosis (35). Similarly, Jarvis et al. reported 
that pretreatment  of an HL-60 cell variant with either syn- 
thetic DG or exogenous phospholipase C blocked TNF- and 
ceramide-mediated apoptosis (31). Haimovitz-Friedman et al. 
(2) showed that phorbol ester or DG generated in response 
to basic fibroblast growth factor blocked ionizing radiation- 
induced apoptosis in primary cultures  of bovine aortic en- 
dothelial cells, an event mediated by activation of neutral sphin- 
gomyelinase.  Recently,  Grant  and  co-workers  studied  the 
reciprocal regulation of apoptosis through DG and ceramide 
in  detail,  demonstrating  that  even  non-tumor-promoting 
phorbol esters were capable of inhibiting ceramideoinduced 
apoptosis and that  down-regulation  of PKC by prolonged 
exposure  to phorbol  ester  abrogated  DG  inhibition  (36). 
Hence, a substantial amount of evidence has been accumu- 
lated in a relatively brief time to argue that DG protects cells 
from the lethal  effects  of ceramide stimulation. 
Since ceramide generation appears involved in both prolifer- 
ation and apoptosis, events leading to apoptosis must somehow 
be suppressed in  the presence of DG for proliferation  and 
differentiated functions  to prevail.  However, more detailed 
information about the elements involved in the signal trans- 
duction pathway generated in response to a selective cera- 
mide elevation will be required  to  ascertain  which  events 
mediate ceramide-induced apoptosis.  Thereafter,  it may be 
possible to delineate which of these elements  proceed and 
which may need to be attenuated in the presence of DG to 
switch  the  downstream  flow of events from  apoptosis  to 
differentiation or proliferation. The use of synthetic lipid an- 
alogues to generate isolated elevations in the cellular level of 
these second messengers should be invaluable for this purpose. 
This commentary attempts to provide a framework to in- 
terpret data that  appear contradictory by implicating  cera- 
mide in both cell proliferation and apoptosis.  A similar conun- 
drum surrounds the role of myc in these processes (37). The 
hypothesis that the effect of ceramide depends not only on 
the genetics of the system but also on the microenvironment, 
i.e., the context in which the signal is generated determines 
the outcome, is a testable one. In at least one system, prelim- 
inary data suggest that  ceramide might  serve,  even within 
the same cell,  as a signal for distinct and perhaps mutually 
exclusive events. If reciprocal regulation through DG and cer- 
amide is a generic mechanism for regulation of apoptosis and 
proliferation,  it may be possible to delineate the subset of 
intracellular  signaling  events that comprise an obligatory path 
committed to the apoptotic process. The studies of Boucher 
et al. (1) and Cifone et al. (3) dearly show that there is nothing 
inherent  in the structure of ceramide that designates life or 
death. 
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